Showing results (671-680 of 764) with videos related to

Sort By:
Pageof 77
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 12, 2018
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in EuropeMuhammad Ahsan Javed, Georg Beyer, Nha Le, et al.
Plos One|March 22, 2014
Inflammation-induced acute phase response in skeletal muscle and critical illness myopathyClaudia Langhans, Steffen Weber-Carstens, Franziska Schmidt, et al.
Nature Genetics|July 1, 2008
Identification of renal Cd36 as a determinant of blood pressure and risk for hypertensionMichal Pravenec, Paul C Churchill, Monique C Churchill, et al.
European Urology Focus|July 3, 2026
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused SamplingThibaut Long-Depaquit, Michael Baboudjian, Arthur Peyrottes, et al.
Cardiovascular Research|August 7, 2016
A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanismAbdelaziz Beqqali, Ilse A E Bollen, Torsten B Rasmussen, et al.
The Journal of Clinical Investigation|October 21, 2015
High salt reduces the activation of IL-4- and IL-13-stimulated macrophagesKatrina J Binger, Matthias Gebhardt, Matthias Heinig, et al.
Investigational New Drugs|May 21, 2017
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase CKhaldoun Almhanna, David Wright, Teresa Macarulla Mercade, et al.
The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.
Science (New York, N.Y.)|August 29, 2015
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathyJohn T Hinson, Anant Chopra, Navid Nafissi, et al.
Cancers|April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 TrialAnneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Pageof 77